A tyrosine sulfation–dependent HLA-I modification identifies memory B cells and plasma cells
Justin Tze Ho Chan(University of Toronto), Götz R. A. Ehrhardt(University of Toronto), Max D. Cooper(Brighton and Sussex Medical School), Evan J. Propst(Hospital for Sick Children), Joan Wither(University Health Network), Leslie Y. T. Leung(University of Toronto), Christopher W. Cairo(University of Alberta), Jonathan St‐Germain(Hospital for Sick Children), Mengyao Shi(Tulane University), Alexander F. Palazzo(University of Toronto), Judi Yang(University of Toronto), Amit Bar‐Or(University of Pennsylvania), Srijit Khan(University of Toronto), Yanling Liu(University of Toronto), Paolo Campisi(Hospital for Sick Children), Eyal Grunebaum(University of Toronto), Michael F. Moran(University of Toronto), Chunxia Zou(University of Alberta), Theresa Holler(Hospital for Sick Children)
Cited by 18
Related Papers
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
|New England Journal of Medicine|2016|1.9k
Multiple sclerosis
|Nature Reviews Disease Primers|2018|1.4k
Non-coding RNA: what is functional and what is junk?
|Frontiers in Genetics|2015|912